ArchiveRational drug use is a key component of medical safety. Participation in the consultation of infectious diseases is the primary opportunity for clinical pharmacists to integrate into the clinical treatment. With the deepening of the consultation work, clinical pharmacists play an increasingly important role in the treatment of adult infectious diseases. However, there is a serious lack of participation in the formulation and adjustment of anti-infective programs for newborns, especially premature infants. By collecting the literature reports of clinical pharmacists participating in the anti- infective treatment of premature infants published in China, this paper summarized the effect and experience of clinical pharmacists participating in the anti-infective consultation of premature infants, and expounded the experience of clinical pharmacists integrating into the treatment team from the professional characteristics, giving full play to their advantages and due roles.
Preterm infants are at high risk of infection because of their immature organs and immune system. There were many risk factors of infection in premature infants, including gestational age, birth weight, gender, Apgar score, feeding intolerance and underlying diseases. Maternal factors were included, such as multifetation, chorioamnitis, amniotic fluid contamination, premature rupture of membranes, cesarean section, vaginal rupture bacteria and diseases of pregnancy. Iatrogenic factors included invasive procedures, use of hormones and broad-spectrum antibiotics, long-term parenteral nutrition, and longer hospital stay. This paper summarized the risk factors and prevention measures of premature infant infection, in order to arouse clinical attention to premature infant infection, strengthen hospital management and family monitoring, reduce the risk of infection, reduce the mortality of premature infants.
The clinical mortality rate of septicemia of premature infants is high. Coagulase-negative Staphylococcus and Staphylococcus aureus are the main pathogens of this disease, and vancomycin is the common treatment. The administration of premature infants should not only ensure the best efficacy, but also minimize nephrotoxicity and ototoxicity. At present, the guidelines of various countries have not reached consensus on the monitoring indicators of blood concentration of vancomycin in premature infants, the target range of indicators, and the initial administration plan. In this paper, the pharmacokinetic characteristics of vancomycin in premature infants, blood concentration monitoring indicators, target range of indicators, initial treatment plan, drug safety literature were reviewed, to provide some reference for clinical drug use.
Congenital candidiasis is a common complication in neonatal units, occurring in both term infants and premature infants. Children may present as skin infections, severe cases may have systemic infection. The early diagnosis of congenital candidiasis is difficult, and the experience of diagnosis and treatment is mostly from case reports, which is easy to delay treatment. The treatment plan mainly considers the high risk factors, gestational age, birth weight and clinical manifestations. This article reviewed the progress in diagnosis and treatment of congenital candidiasis, in order to provide some reference for the early diagnosis and treatment of such infections.
To study the effects of nobiletin on oxidized low-density lipoprotein (ox-LDL) induced human brain microvascular endothelial cells (HBMECs) injury, and further to analyze whether its mechanism is related to the regulation of microRNA (miR)-374a-3p expression.
HBMECs were cultured with 50 μg/mL ox-LDL to establish an cell injury model in vitro. HBMECs were divided into control (Con) group, ox-LDL group, ox-LDL+nobiletin low-dose group, ox-LDL+nobiletin medium-dose group, ox-LDL+nobiletin high-dose group, LDL+miR-NC group, ox-LDL+miR-374a-3p group, ox-LDL+nobiletin+anti-miR-NC group, ox-LDL+nobiletin+anti-miR-374a-3p group. The commercial kit was applied to detect the content of malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) and catalase (CAT) in cells. Cell apoptosis rate and miR-374a-3p expression were analyzed.
Compared with the Con group, the MDA level and apoptosis rate in the ox-LDL group were significantly increased (P<0.01), SOD and CAT activity, and miR-374a-3p expression were significantly decreased (P<0.01). Compared with the ox-LDL group, the MDA level and apoptosis rate in the ox-LDL+nobiletin low-dose group, ox-LDL+nobiletin middle-dose group and ox-LDL+nobiletin high-dose group were significantly reduced (P<0.01), SOD and CAT activity, miR-374a-3p expression were significantly increased (P<0.01). Compared with the ox-LDL+miR-NC group, the MDA level and apoptosis rate in the ox-LDL+miR-374a-3p group were significantly reduced (P<0.01), and SOD and CAT activity were significantly increased (P<0.01). Compared with the ox-LDL+nobiletin+anti-miR-NC group, the MDA level and apoptosis rate of the cells in the ox-LDL+nobiletin+anti-miR-374a-3p group were significantly increased (P<0.01), SOD and CAT activity was significantly reduced (P<0.01).
Nobiletin could reduce ox-LDL induced HBMECs apoptosis and oxidative stress injury by up-regulating miR-374a-3p expression.
To investigate the value of plasma microRNA (miR)-126 expression in predicting cerebral collateral circulation in patients with severe carotid stenosis.
A total of 55 patients with carotid stenosis≥70% diagnosed by vascular ultrasound from Gongli hospital in Pudong new area, Shanghai from January 2017 to January 2019 were collected. Digital subtraction angiography was used to detected the establishment of cerebral collateral circulation, quantitative reverse transcription polymerase chain reaction was used to detect the expression of plasma miR-126-3p. Multi-factor logistic regression and receiver operating characteristic (ROC) curve were used to analyze the correlation between the expression of miR-126-3p and the establishment of cerebral collateral circulation.
There were 32 males and 23 females, with an average age of (66.19±7.78) years, including 15 cases in grade 0 group (without rami), 16 cases in grade 1 group (grade 1 collateral circulation), 10 cases in grade 2 group (secondary collateral circulation), 14 cases in grade 3 group (tertiary collateral circulation). Another 55 healthy subjects were tested for miR-126-3p as control group. The overall expression level of miR-126-3p was different between severe carotid artery stenosis and control group (P<0.05). The expression level of grade 3 group was greater than grade 0 - 2 group (P<0.05). In terms of clinical characteristics, the proportion of statin treatment history in grade 3 group was significantly higher than that in grade 1 - 2 and grade 0 group, with statistical significance (P<0.05). Combined with the treatment history of statins, ROC curve showed that miR-126-3p had a high value in predicting the establishment of tertiary collateral circulation, the area under the curve was 0.878.
Plasma miR-126 expression may be a biomarker of tertiary collateral circulation establishment in patients with severe carotid stenosis.
To evaluate the efficacy of different routes of administration of glucocorticoid nebulization and systemic therapy in diabetes mellitus type 2 (T2DM) patients combined with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
Patients with T2DM combined with AECOPD with good glycemic control in our respiratory department from July 2019 to December 2021 were included. All patients were randomly divided into control group, intravenous injection group and nebulized group by random number table method, 35 cases in each group. All patients received routine treatment. The control group was not routinely treated with glucocorticoids, the intravenous injection group received systemic glucocorticoid therapy with methylprednisolone sodium succinate, and the nebulized group inhaled budesonide. Pulmonary function, arterial blood gas indexes and blood glucose metabolism indexes were compared among the three groups after 1 week and 1 month after treatment.
Compared with the control group, forced expiratory volume in the first second [(1.32±0.13) L vs (1.21±0.17) L, (1.38±0.18) L vs (1.21±0.17) L, (1.41±0.14) L vs (1.31±0.15) L, (1.47±0.20) L vs (1.31±0.15) L] and arterial partial pressure of oxygen in intravenous injection group and nebulized group were significantly higher at 1 week and 1 month after treatment (P<0.05). In addition, the fasting blood glucose levels in intravenous injection group and nebulized group were significantly higher at 1 week and 1 month after treatment, but the nebulized group had less effect on fasting blood glucose than intravenous injection group [(8.10±0.34)mmol/L vs (6.38±0.58)mmol/L, (6.89±0.41)mmol/L vs (6.20±0.60)mmol/L](P<0.05).
In T2DM patients combined with AECOPD, glucocorticoids can significantly shortened the course of the disease, and the clinical effect was significantly better than that of conventional treatment. The clinical effect of aerosol inhalation was similar to that of systemic use of glucocorticoids, and aerosol inhalation was superior to systemic use in blood glucose control.
To analyze the effects of secukinumab combined with topical shikonin on immune inflammatory indexes and skin barrier function in patients with recurrent moderate-to-severe plaque psoriasis.
A total of 70 patients with recurrent moderate-to-severe plaque psoriasis in our hospital from January 2020 to January 2022 were selected and divided into observation group and control group according to the random number table method, with 35 cases in each group. Both groups received conventional treatment, and the control group was added with secukinumab, and the observation group was added with secukinumab and shikonin. The two groups were treated continuously for 12 weeks, the curative effect was evaluated and the occurrence of adverse reactions were recorded. Changes in psoriasis area and severity index (PASI) score, neutrophil-to-lymphocyte ratio (NLR), dermatological quality of life index (DLQI) score, serum tumor necrosis factor (TNF)-α, interleukin (IL)-17, IL-23 levels, stratum corneum water content and sebum content before and after treatment were analyzed.
The total effective rate of the observation group was 94.59% higher than that of the control group (74.29%), the difference was significant (P<0.05). After treatment, the PASI score, DLQI score and NLR of the observation group were lower than those of the control group (P<0.05). Compared with the control group, the water content and sebum content in the stratum corneum in the observation group were higher, and serum levels of TNF-α, IL-17 and IL-23 were lower (P<0.05).
Secukinumab combined with topical shikonin is effective in the treatment of recurrent moderate-to-severe plaque psoriasis. It can effectively regulate immune inflammatory indexes, improve skin barrier function, alleviate the disease condition, improve the quality of life of patients, and ensure the safety.
To study the effects of Bushen Antai recipe on fetal agitation (FA) and uterine hemodynamics and inhibin (INH)-A.
Ninety-two patients with FA in the first ward of obstetrics, the second people's hospital of Liaocheng from January 2021 to November 2021 were selected and divided into observation group (n=47) and control group (n=45) according to simple random number table method. The control group was given progesterone (P), and the observation group was given Bushen Antai recipe on the basis of control group. Clinical efficacy, uterine hemodynamics [resistance coefficient (RI), systolic/diastolic ratio (S/D), pulsatility index (PI)], β-human chorionic gonadotropin (hCG), P, estradiol (E2) and INH-A levels and pregnancy outcome were compared between the two groups.
The total effective rate of observation group was significantly higher than that of control group (95.74% vs 75.55%, P<0.05). The levels of RI, S/D, PI, preterm birth of observation group were lower than those of the control group, the differences were statistically significant (P<0.05). The levels of β-hCG, P, E2, INH-A, full-term pregnancy of the observation group were higher than those in the control group, the differences were statistically significant (P<0.05).
Bushen Antai recipe can effectively improve the clinical symptoms of patients with FA, promote microcirculation, improve uterine hemodynamics and increase the level of INH-A, with significant effect.
To investigate the effects of Wuling powder combined with moxa-wool moxibustion on joint swelling and functional rehabilitation after total knee arthroplasty (TKA).
A total of 105 TKA patients who received treatment in the department of orthopedics, people's hospital of Xinjiang Uygur autonomous region from January 2020 to January 2021 were selected and randomly divided into control group (n=52) and experimental group (n=53) according to random number table method. The control group was given basic detumescence and analgesic treatment, and the experimental group was given Wuling powder combined with moxibustion. Visual analogue scale (VAS) and American hospital for special surgery knee score (HSS) were used to evaluate pain before surgery and 3, 7 and 15 days after surgery, respectively. Thigh circumference, calf circumference and knee circumference were measured, and erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and interleukin (IL)-6 levels were examined.
The operation was successfully completed in both groups. 4 patients (3 in the control group and 1 in the experimental group) showed incision skin margin necrosis, which healed after debridement and dressing change. 2 cases of deep vein thrombosis (1 case in the control group and 1 case in the experimental group) were diagnosed as intramuscular venous plexus thrombosis and were eliminated. After treatment, the total effective rate of experimental group was 94.34%, which was higher than that of control group (75.00%), and the difference was statistically significant (P<0.05). At day 7 and 15 after surgery, thigh circumference, knee circumference and calf circumference in 2 groups were significantly higher than those before surgery, with statistical significance (P<0.05). After day 7 and 15, the thigh circumference and knee circumference of the experimental group were significantly lower than those of the control group, with statistical significance (P<0.05). The VAS score of the experimental group was significantly lower than that of the control group at day 3, 7 and 15 after surgery, with statistical significance (P<0.05). The HSS score of the experimental group was significantly better than that of the control group 15 days after surgery, the difference was statistically significant (P<0.05). The levels of CRP and IL-6 in experimental group were significantly lower than those in control group 7 days after surgery, with statistical significance (P<0.05). The levels of ESR, CRP and IL-6 in experimental group were lower than those in control group 15 days after surgery, with statistical significance (P<0.05).
Wuling powder combined with moxa-wool moxibustion can significantly reduce joint swelling, relieve pain and improve knee function after TKA.
To explore the effect of methylprednisolone in the adjuvant treatment of endometriosis (EMT) combined with early recurrent spontaneous abortion (ERSA) and its effects on levels of soluble FMS-like tyrosine kinase (sFlt)-1, vascular endothelial growth factor (VEGF) and C reactive protein (CRP).
A total of 85 patients with EMT complicated with ERSA treated in department of obstetrics and gynecology, Minquan county hospital of traditional Chinese medicine from June 2019 to June 2020 were selected and divided into observation group (n=43) and control group (n=42) by random number table method. The control group was given gonadotropin-releasing hormone agonist, and the observation group was given methylprednisolone adjuvant therapy on the basis of the control group. Clinical efficacy, serum sFlt-1, VEGF, CRP, estradiol (E2), progesterone (P), and follicle-stimulating hormone (FSH), luteinizing hormone (LH), interleukin (IL)-6, tumor necrosis factor (TNF)-α, D-dimer (D-D), prothrombin time (PT), activated partial thromboplastin time (APTT) levels and the incidence of adverse reactions were compared between the two groups.
After treatment, the total effective rate of observation group was higher than that of control group (95.35% vs 69.05%), and the difference was statistically significant (P<0.05). Serum sFlt-1 and D-D in both groups were higher than before treatment, and the observation group was higher than the control group (P<0.05). The levels of VEGF, E2, P, FSH, LH, IL-6, TNF-α, CRP, PT and APTT in both groups were lower than before treatment, and the observation group was lower than the control group (P<0.05).
Methylprednisolone adjuvant therapy has a significant effect in EMT patients complicated with ERSA, which may be related to the effective improvement of sFlt-1, VEGF and CRP levels.
To investigate the effect of caprost amine triol combined with uterine balloon placement on postpartum placenta previa hemorrhage and coagulation function.
A total of 110 patients with postpartum placenta previa hemorrhage admitted to department of obstetrics, Gansu provincial maternal and child health hospital from May 2019 to September 2021 were selected and divided into observation group (n=56) and control group (n=54) according to hemostasis methods. The control group was given uterine balloon placement, and the observation group was given caprost amine triol on the basis of the control group. The clinical efficacy, coagulation function, surgical indexes, duration of contractions, descending speed of fundus, duration of lochia and occurrence of adverse reactions were compared between the two groups.
After treatment, the total effective rate of observation group was higher than control group (94.64% vs 70.37%), the difference was statistically significant (P<0.05). Postpartum prothrombin time, activated partial thrombin time and thrombin time of two groups were significantly increased, and observation group was lower than the control group (P<0.05). Fibrinogen decreased in both groups, and the observation group was higher than the control group (P<0.05). The operation time, intraoperative blood loss, postoperative blood loss and hospital stay in the observation group were lower than those in the control group (P<0.05). The duration of contractions and the descending speed of fundus in the observation group were higher than those in the control group, while the duration of lochia was lower than that of the control group (P<0.05). The incidence of adverse reactions in observation group was lower than that in control group (3.57% vs 16.67%), and the difference was statistically significant (P<0.05).
Caprost amine triol combined with uterine balloon placement is effective in patients with placental previa postpartum hemorrhage, and can improve coagulation function in a certain extent.
To investigate the effects of phentolamine combined with fasudil in the treatment of pulmonary heart disease and to analyze the effects of serum growth differentiation factor (GDF)-15 and galectin-3.
A total of 105 patients with pulmonary heart disease who received treatment in the outpatient department of cardiology, general hospital of Taiyuan iron and steel (group) Co., ltd., from June 2019 to June 2021 were selected and divided into observation group (n=53) and control group (n=52) by random number table method. The control group was given phentolamine treatment, and the observation group was given fasudil treatment on the basis of the control group. Clinical efficacy, serum GDF-15, galectin-3, cardiac output (CO), left ventricle ejection fraction (LVEF), 6 minute walking test (6MWT), forced expiratory volume in one second (FVC1), forced vital capacity (FVC), ratio of forced expiratory volume in first second (FEV1) accounted for FVC (FEV1/FVC) and the incidence of adverse reactions were compared in the two groups.
After treatment, the total effective rate of the observation group was higher than that of the control group (92.45% vs 67.31%), and the difference was statistically significant (P<0.05). After treatment, the serum levels of GDF-15 and galectin-3 in two groups were decreased compared with before treatment, and the observation group was lower than the control group (P<0.05). The CO, LVEF and 6MWT in two groups were higher than before treatment, and observation group was higher than control group (P<0.05). The levels of FEV1, FVC and FEV1/FVC in the two groups were higher than before treatment, and the observation group was higher than the control group (P<0.05).
Phentolamine combined with fasudil is effective in the treatment of patients with pulmonary heart disease, which may be related to the effective improvement of serum GDF-15 and galectin-3 levels.
To explore effects of granulocyte colony-stimulating factor (G-CSF) combined with methylprednisolone in the treatment of multiple sclerosis (MS) and its effects on immunoglobulin (Ig), matrix metalloproteinase (MMP)9 and tissue inhibitor of metalloproteinase (TIMP)1.
A total of 127 MS patients treated department of neurology, Dongying district people's hospital from January 2019 to November 2021 were selected and divided into experimental group (n=64) and control group (n=63) by random number table method. The control group was given methylprednisolone treatment, and the experimental group was given G-CSF on the basis of the control group. The clinical efficacy, Ig, MMP9, TIMP1, T lymphocyte subsets, MS multiple sclerosis impact scale (MSIS) score, multidimensional fatigue inventory (MFI) score and the occurrence of adverse reactions were compared between the two groups.
After treatment, the total effective rate of experimental group was higher than that of control group (87.50% vs 69.84%), the difference was statistically significant (P<0.05). The levels of IgA, IgG, IgM, MMP9, CD3+, CD4+, CD4+/CD8+, MSIS and MFI score in both groups were decreased over time, and the test group was lower than the control group (P<0.05). The level of TIMP1 was increased with time, and the test group was higher than the control group (P<0.05).
In MS patients, G-CSF combined with methylprednisolone has a significant effect, which can effectively improve the levels of Ig, MMP9 and TIMP1, and with good safety.
To evaluate the economic value of denosumab compared with alendronate and zoledronate in the treatment of postmenopausal women with osteoporosis (OP) from the perspective of Chinese health system.
Markov model was established and the treatment period was set to 5 years. The clinical efficacy, health benefits and cost data were obtained from published literatures. Lifetime disease outcomes, effectiveness and costs were calculated under each intervention. With the incremental cost-effectiveness ratio (ICER) as the index, the economy of each intervention was evaluated under the threshold of 3 times GDP per capita. Situation analysis, single factor sensitivity analysis and probability sensitivity analysis were used to test the robustness of the results.
The total costs were 19 268, 18 324 and 22 386 yuan in the groups of denosumab, alendronate and zoledronate, respectively. Total quality-adjusted life year (QALY) were 7.58, 7.53 and 7.56. Compared with alendronate, denosumab increased QALY by 0.05, ICER was 18 279 yuan per QALY, which was much lower than 1 times GDP per capita and more economical. Compared with zoledronate, denosumab resulted in an additional 0.03 QALYs and a lower cost, showing absolute advantage. Sensitivity analysis proved the robustness of the results.
In the treatment of postmenopausal women with OP, denosumab is more economical than alendronate and has absolute advantages over zoledronate.
By analyzing the utilization of monoclonal antibody drugs in sample hospitals in Shanghai in the past three years, the overall development of monoclonal antibody drugs was understood, so as to provide reference for clinical rational drug use.
The clinical sampling data of monoclonal antibody drugs in sample hospitals in Shanghai from 2019 to 2021 were collected from the Hospital Prescription Analysis System database of China National Pharmaceutical Industry Information Center to analyze the clinical application of monoclonal antibody drugs in the past three years.
From 2019 to 2021, the number of monoclonal antibody drugs prescriptions and antitumor drugs prescriptions in sample hospitals in Shanghai increased year by year, and the prescription amount fluctuated. The trend of the number of prescriptions and the amount of prescriptions in medical institutions at all levels was basically the same. From 2019 to 2021, trastuzumab, rituximab and bevacizumab had the highest cumulative number of prescriptions and amount of prescriptions. From the market share and year-on-year analysis, it could be seen that the compound growth rate of adalimumab is the fastest, which has reached 1 200%, and pertuzumab is the second fastest, which nearly 700%, meanwhile, the market share is also relatively high, nearly 15%. In 2021, the treatment of monoclonal antibody drugs in sample hospitals in Shanghai mainly focused on anti-tumor therapy. The indications with more prescriptions of monoclonal antibody drugs for tumor treatment were breast cancer, intestinal cancer and lymphoma, respectively. The drugs with the largest number of prescriptions were trastuzumab, pertuzumab, bevacizumab, rituximab and cetuximab.
Monoclonal antibody drugs has been widely used in clinical practice, and the use of monoclonal antitumor drugs is occupy a dominant position.
Gestational diabetes mellitus (GDM) is one of the common complications during pregnancy, conferring an increased risk of long-term abnormal glucose metabolism and cardiovascular disease for both mother and children. Due to socioeconomic factors, patients' health awareness and family-related practicalities, less than 50% of women with GDM partake in postpartum glucose testing. Based on the existing research evidence, this paper summarized some strategies and suggestions for standardized postpartum management of GDM and improvement of follow-up rate, aiming to improve the public and medical staffs' awareness of standardized postpartum management of GDM and the level of hospital management.
Treatment of different diseases with same method is one of the characteristics and essence of traditional Chinese medicine (TCM). How to use scientific methods and objective data to verify the effect of syndrome differentiation and treatment of different diseases with same method, and to provide high-quality clinical evidence, is the current hot spot and difficulty in the field of TCM clinical research. This paper combined innovative clinical basket design method and decision model, and took the clinical research model of treatment of different gynecological diseases with same method of TCM as the entry point, so as to provide some suggestions and thoughts on how to better reflect the theory of treatment of different diseases with same method in precision medicine, and establish the clinical research model of treatment of different diseases with same method of TCM "combination of syndrome and disease".
Ulcerative colitis (UC) is a chronic nonspecific inflammatory disease of the colorectal, and its pathogenesis has not been fully defined. Hypoxia-inducible factor (HIIF)-1α is directly or indirectly involved in the pathogenesis of UC, causing intestinal flora imbalance, resulting in the increase of enterogenic and conditioned pathogens, and the destruction of intestinal mucosal barrier structure, resulting in increased vascular permeability. Intestinal bacteria and bacterial products migrate to mucosal laminae propria, causing activation of immune cells and infiltration of inflammatory cells, thus increasing the level of serum pro-angiogenesis factors and imbalance of the effect of angiogenesis inhibitors, leading to pathological angiogenesis, thus inducing the progression of UC. This paper mainly summarized the mechanism of HIF-1α in the UC process, and provides innovative ideas for the treatment of ulcerative colitis by this factor and drug development.
Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by persistent respiratory symptoms and airflow restriction, caused by airway and/or alveolar abnormalities resulting from significant exposure to harmful particulate matter or gases. Difficulty breathing, cough and/or phlegm are the most common symptoms of COPD. The incidence and mortality of COPD are increasing year by year and is the fourth leading cause of death worldwide. Reactive oxygen species produced by cigarette smoke can damage lung structure and function, causing pulmonary oxidative stress disorder and COPD. Oxidative stress is the key to the pathogenesis of COPD. Traditional COPD drugs have limited ability to control oxidative stress, and clinical evidence of antioxidant stress is insufficient. Thioredoxin and N-acetyl-L-cysteine as molecules of the body's own antioxidant defense system have become research hotspots. This paper reviewed the pathogenesis of oxidative stress and research hotspot of antioxidants of COPD to provide reference for clinical practice.